Figure 2
From: Effect of apigetrin in pseudo-SARS-CoV-2-induced inflammatory and pulmonary fibrosis in vitro model
Evaluation of in vitro PF model. MRC-5 cells were treated with CMPSCV from MH-S (A) or THP-1 (B) cells for 24 h. Cell lysates were prepared and subjected to western blotting to analyze the CTGF, COLA1, α-SMA, HIF-1α, and β-actin expressions. The results are presented as the mean ± SD of three independent experiments. **p < 0.01, and ***p < 0.001 (compared to normal control).
